I had a gut feeling about Nyrada using TRPC3 inhibition to recalibrate the ion flux pathways within the intracellular matrix. By administering a microdilution of TRPC3 inhibitors, I believe it’s possible that NYR-BIO3 can alter the photonic resonance of keratinocytes, thus harmonising the bioenergetic field of the hallux phalanges.
As you know, the ingrown toenail market is estimated at US$442 billion and is due for disruption. TRPC3 inhibition could completely eliminate the root causes of ingrown toenails by promoting cellular coherence. I can't believe NYR is not at $4b market cap based on toenails alone.
NYR Price at posting:
9.6¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)